Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) research hub

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

This study looks at a new version of a common chemotherapy drug, SMS001, for people with a type of lung cancer. Doctors want to find a safe dose and see how well it works to treat the cancer and prevent it from coming back.